Metraipolis › archive › dc_8f00c799e286

From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum — Europe PMC PMID:41690944

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41690944
DOI
10.1038/s41467-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-11-05T19:57:56.482Z
SHA-256 of the archived text
58c1d287f4a8d772891845c6547c160b026b0a2fdaa887a6d16eebdc8d0e4bbd
Stable URL of this page
https://metraipolis.com/documento/dc_8f00c799e286

How to cite

From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum — Europe PMC PMID:41690944 — Europe PMC (en), https://europepmc.org/article/MED/41690944 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8f00c799e286 (Metraipolis archive dc_8f00c799e286, sha256 58c1d287f4a8d772891845c6547c160b026b0a2fdaa887a6d16eebdc8d0e4bbd)
BibTeX
@misc{dc8f00c799e286,
  title = {From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum — Europe PMC PMID:41690944},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41690944},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8f00c799e286; sha256 58c1d287f4a8d772891845c6547c160b026b0a2fdaa887a6d16eebdc8d0e4bbd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41690944. Agents can read the archived copy with the MCP tool read_document.